ClinicalTrials.gov record
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
TERMINATED · NCT00346229
Trial record
NCT IDNCT00346229
Status
TERMINATED
Study type
INTERVENTIONAL
Phase
PHASE1
Enrollment
29
Conditions
Breast Cancer
Interventions
filgrastim, pegfilgrastim, lyso-thermosensitive liposomal doxorubicin(Thermodox), hyperthermia treatment
Locations
Duke Cancer Institute, Durham, North Carolina, United States
Indexed topics
Last update
2016-03-18